Utama › Glioblastoma › Nebraska
Kajian klinikal Glioblastoma di Nebraska
5 kajian untuk Glioblastoma sedang mencari peserta di lokasi di Nebraska.
Bandar di Nebraska
Teks kajian rasmi (Bahasa Inggeris)
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
- University of Nebraska Medical Center, Omaha
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
- University of Nebraska Medical Center, Omaha
Mengambil pesertaFasa 1
Umur 19 ke atas · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05698524Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
- Nebraska Cancer Specialists (Midwest Cancer Center - Legacy), Omaha
- XCancer Omaha / Urology Cancer Center, Omaha
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Jun 2026 · NCT05283330Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
- University of Nebraska Medical Center, Omaha
Mengambil pesertaFasa 1/2
Umur 19 ke atas · Semua jantina · Dikemas kini 8 Jun 2026 · NCT06011109SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Omaha
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.